9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Autologous Redirected RNA Meso-CIR T Cells

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Autologous Redirected RNA Meso-CIR T Cells

Autologous Redirected RNA Meso-CIR T Cells

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 18

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Adverse Events,  Clinical response Rate,  ,

Interventions: Autologous T cells,

Phase:

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: July 2015

Completion Date: October 2015

Last  Posted Date: September 19, 2017

Location: Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Website Link: https://ClinicalTrials.gov/show/NCT01355965

Was this article helpful?
Dislike 0